Amylyx Pharmaceuticals Balance Sheet (2021-2025) | AMLX

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 50.19M110.40M67.44M107.73M62.53M114.56M247.76M135.26M170.20M170.55M75.00M71.84M77.39M59.76M58.09M225.18M
Short-term Investments 45.93M144.80M139.24M54.86M284.42M231.11M109.52M219.79M201.16M202.74M234.81M162.56M99.11M144.30M122.74M118.81M
Cash & Current Investments 96.12M255.21M206.68M162.59M346.94M345.67M357.28M355.05M371.36M373.29M309.81M234.40M176.50M204.07M180.83M343.99M
Receivables - Net 0.14M15.31M17.55M33.47M29.35M40.05M20.35M4.09M1.73M0.45M0.30M0.10M0.13M
Receivables - Other 0.50M0.30M0.80M0.10M0.50M0.30M0.10M0.10M0.10M0.10M0.10M0.10M
Receivables 0.14M15.81M17.86M34.27M29.45M40.55M20.65M4.19M1.83M0.55M0.40M0.20M0.23M
Raw Materials 0.41M7.15M
Work In Process 0.04M1.68M
Finished Goods 0.11M0.94M
Inventory 0.56M9.77M13.07M24.86M32.37M38.32M
Prepaid Assets 5.39M10.28M9.46M8.34M10.11M12.75M11.79M17.34M14.93M16.89M12.82M9.14M12.48M11.78M5.96M9.26M
Current Assets 104.95M265.49M216.14M172.20M382.13M389.05M427.39M434.11M464.67M410.53M326.72M245.26M189.43M216.14M186.89M353.38M
Non-Current Assets
Property, Plant & Equipment (Net) 0.47M1.29M1.86M2.12M2.61M2.56M2.64M2.76M2.69M2.46M1.47M1.25M0.96M0.82M0.45M0.40M
Other Non-Current Assets 0.20M0.46M0.46M0.72M0.47M0.47M0.47M0.48M0.70M0.49M0.48M0.48M0.02M0.01M2.50M
Non-Current Assets 0.66M8.95M9.10M9.24M9.32M18.91M26.19M32.47M52.79M6.92M5.44M5.45M4.20M3.53M7.71M9.36M
Assets 105.61M274.44M225.24M181.44M391.45M407.96M453.59M466.58M517.45M417.46M332.16M250.71M193.63M219.68M194.60M362.74M
Liabilities
Current Liabilities
Accounts Payables 4.37M10.04M8.12M7.05M6.26M10.77M24.70M6.37M22.06M21.45M4.96M1.49M2.94M4.81M3.29M5.34M
Payables 4.37M10.04M8.12M7.05M6.26M10.77M24.70M6.37M22.06M21.45M4.96M1.49M2.94M4.81M3.29M5.34M
Accumulated Expenses 13.02M16.26M17.26M23.61M38.31M38.75M37.24M37.05M57.72M67.87M62.76M50.46M23.95M12.07M17.46M19.47M
Other Accumulated Expenses 0.26M0.44M0.54M0.36M1.00M
Current Leases 1.41M1.79M1.99M2.04M2.09M2.15M2.20M2.26M2.31M2.37M1.97M1.52M1.05M0.67M0.98M
Total Current Liabilities 17.40M27.71M27.16M32.65M46.61M51.62M64.08M45.62M82.04M91.64M70.08M53.91M28.41M17.93M21.42M25.79M
Non-Current Liabilities
Non-Current Deffered Revenue 0.04M
Preferred Stock Liabilities 239.35M
Operating Leases 5.79M5.29M4.77M4.24M3.69M3.14M2.57M1.98M1.38M0.77M5.10M0.46M0.33M5.30M4.95M
Total Liabilities 17.43M33.49M32.45M37.41M50.85M55.31M67.22M48.18M84.02M93.02M70.85M54.51M28.87M18.26M26.72M30.75M
Shareholder's Equity
Common Equity -151.17M240.95M192.79M144.03M340.61M352.65M386.37M418.40M433.43M324.44M261.31M196.20M164.76M201.42M167.88M332.00M
Shareholder's Equity -151.17M240.95M192.79M144.03M340.61M352.65M386.37M418.40M433.43M324.44M261.31M196.20M164.76M201.42M167.88M332.00M
Liabilities and Shareholders Equity 105.61M274.44M225.24M181.44M391.45M407.96M453.59M466.58M517.45M417.46M332.16M250.71M193.63M219.68M194.60M362.74M
Retained Earnings -155.84M-203.70M-257.80M-311.52M-354.22M-352.65M-330.57M-309.68M-304.95M-423.74M-496.44M-569.15M-606.69M-642.60M-684.04M-718.43M
Treasury Shares 0.60M0.67M0.69M0.74M1.06M1.06M1.08M1.11M2.06M2.91M2.27M2.21M3.17M3.14M2.76M